Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain.

× No keyword cloud information.

12 in total

1. Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol.

Authors: Deepa Rani; Sushma Kaisar; Sushma Awasare; Amit Abhyankar; Sandip Basu
Journal: Eur J Nucl Med Mol Imaging Date: 2014-04-01 Impact factor: 9.236

Review 2. Papillary thyroid cancer: medical management and follow-up.

Authors: Richard T Kloos
Journal: Curr Treat Options Oncol Date: 2005-07

Review 3. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors: Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal: Thyroid Date: 2016-01 Impact factor: 6.568

4. What's in the Image? Pituitary Metastasis from Papillary Carcinoma of the Thyroid: A Case Report and a Comprehensive Review of the Literature.

Authors: Marko Stojanović; Sandra Pekić; Mirjana Doknić; Dragana Miljić; Slavica Cirić; Aleksandar Diklić; Svetislav Tatić; Miloje Joksimović; Emilija Manojlović-Gačić; Milica Skender-Gazibara; Vera Popović
Journal: Eur Thyroid J Date: 2012-11-09

Review 5. Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer.

Authors: Chao Ma; Jiawei Xie; Wanxia Liu; Guoming Wang; Shuyao Zuo; Xufu Wang; Fengyu Wu
Journal: Cochrane Database Syst Rev Date: 2010-11-10

6. Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.

Authors: Barbara Jarzab; Daria Handkiewicz-Junak; Józef Roskosz; Zbigniew Puch; Zbigniew Wygoda; Aleksandra Kukulska; Beata Jurecka-Lubieniecka; Kornelia Hasse-Lazar; Maria Turska; Aleksander Zajusz
Journal: Eur J Nucl Med Mol Imaging Date: 2003-05-29 Impact factor: 9.236

Review 7. Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.

Authors: Joanna Klubo-Gwiezdzinska; Kenneth D Burman; Douglas Van Nostrand; Mihriye Mete; Jacqueline Jonklaas; Leonard Wartofsky
Journal: Endocr Pract Date: 2013 Jan-Feb Impact factor: 3.443

8. Analysis of Clinical Factors for the Determination of Optimal Serum Level of Thyrotropin After Recombinant Human Thyroid-Stimulating Hormone Administration.

Authors: Seung Hyun Son; Sang-Woo Lee; Ji-Hoon Jung; Choon-Young Kim; Do-Hoon Kim; Shin Young Jeong; Byeong-Cheol Ahn; Jaetae Lee
Journal: Nucl Med Mol Imaging Date: 2015-09-01

9. Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management.

Authors: Ann Gramza; Kathryn G Schuff
Journal: Onco Targets Ther Date: 2009-01-01 Impact factor: 4.147

10. Effect of recombinant human thyrotropin on the uptake of radioactive iodine (¹²³I) in dogs with thyroid tumors.

Authors: Miguel Campos; Kathelijne Peremans; Eva Vandermeulen; Luc Duchateau; Tim Bosmans; Ingeborgh Polis; Sylvie Daminet
Journal: PLoS One Date: 2012-11-29 Impact factor: 3.240